OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Trump's Art of the Deal for Big Pharma, Not Patients

Statement

Date: July 24, 2020
Location: Washington, DC
Issues: Health and Health Care Drugs

Following President Trump's announcement of four executive orders concerning prescription drug prices, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, issued the following statement:

"After 3 ½ years of tweets and bluster, Trump once again delays action to appease his pals at Big Pharma. Instead of real relief from prescription price gouging, Trump lowers prices for nobody this year. He offers only modest orders recycling dormant proposals and a previously rejected, Big Pharma-promoted rebate rule, which will only increase both premiums and government spending. He remains silent on the 2017 request by fifty House members that he use existing authority to lower prices on drugs developed with taxpayer money--such as the many vaccines and treatments currently being developed for COVID-19 using billions of taxpayer dollars."


Source
arrow_upward